Karin Jirström
91 – 100 of 351
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Tumor-associated autoantibodies as early detection markers for ovarian cancer? A prospective evaluation
- Contribution to journal › Article
-
Mark
Relationship between mismatch repair immunophenotype and long-term survival in patients with resected periampullary adenocarcinoma
- Contribution to journal › Article
-
Mark
Stromal progesterone receptor expression and long-term survival in patients with resected periampullary adenocarcinoma
(2018) In Annals of oncology : official journal of the European Society for Medical Oncology 29(Suppl. 8). p.262-263
- Contribution to journal › Published meeting abstract
-
Mark
Pre-diagnostic anthropometry, sex, and risk of colorectal cancer according to tumor-infiltrating immune cell composition
(2018) In Annals of oncology : official journal of the European Society for Medical Oncology 29(Suppl. 8). p.180-180
- Contribution to journal › Published meeting abstract
-
Mark
Discovery of KIRREL as a biomarker for prognostic stratification of patients with thin melanoma
(2018) In Annals of oncology : official journal of the European Society for Medical Oncology 29(Suppl. 8). p.463-463
- Contribution to journal › Published meeting abstract
-
Mark
Prognostic significance of lymphocyte-activation gene-3 expression in chemoradiotherapy-naïve esophageal and gastric adenocarcinoma
(2018) In Annals of oncology : official journal of the European Society for Medical Oncology 29(Suppl. 8). p.220-220
- Contribution to journal › Published meeting abstract
-
Mark
Analytical validation of OncoMasTR, a multigene test for predicting risk of distant recurrence in hormone receptor-positive early stage breast cancer
(2018) In Annals of oncology : official journal of the European Society for Medical Oncology 29(Suppl. 8). p.65-65
- Contribution to journal › Published meeting abstract
-
Mark
A Biological Signature for Breast Ductal Carcinoma In Situ to Predict Radiotherapy Benefit and Assess Recurrence Risk
(2018) In Clinical cancer research : an official journal of the American Association for Cancer Research 24(23). p.5895-5901
- Contribution to journal › Article
- 2017
-
Mark
The prognostic impact of COX-2 expression in breast cancer depends on oral contraceptive history, preoperative NSAID use, and tumor size
- Contribution to journal › Article
-
Mark
Coffee, tea and melanoma risk : findings from the European Prospective Investigation into Cancer and Nutrition
- Contribution to journal › Article
